MedPath

Effectiveness of pyrroloquinone quinone amino acid on mental status of Japanese subjects

Not Applicable
Conditions
Healthy adult
Registration Number
JPRN-UMIN000032270
Lead Sponsor
Kagawa Nutrition University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1.The person who had a mental disease, the brain functional disorder in the past 2.The person with the cerebrovascular disorder 3.The person who took a drug or a supplement about a brain function or bloodstream improvement within three months before examination start 4.The person with gelatine allergy 5.The pregnant or nursing woman 6.The person who wasn't pamitted the paticipation by the docor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We compared the reaction time with the correct answer rate of the cognitive problem before and after the PQQ intake. We examined it in the near-infrared light brain function imaging device(NIRS:Near Infra-Red Spectoroscopy) which can observe a bloodstream state of the brain directly.It is the measurement in base line between parallel two groups of PQQ intake group and the placebo food intake group and 12 weeks later.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath